115180 — Qurient Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual income statement for Qurient Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	4,886	8,469	9,032	9,180	6,983
Cost of Revenue
Gross Profit	885	1,782	1,763	1,351	930
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	29,129	35,943	32,245	36,657	36,748
Operating Profit	-24,243	-27,475	-23,213	-27,478	-29,765
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-23,884	-27,118	-22,249	-24,997	-31,262
Provision for Income Taxes
Net Income After Taxes	-23,681	-27,118	-22,249	-24,997	-31,262
Minority Interest
Net Income Before Extraordinary Items
Net Income	-22,848	-25,457	-21,117	-24,111	-30,054
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-22,848	-25,457	-21,117	-24,111	-30,054
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1,696	-1,392	-1,551	-810	-871
Dividends per Share